Market Cap (In SEK)
345.45 Million
Revenue (In SEK)
-
Net Income (In SEK)
-22.87 Thousand
Avg. Volume
37.45 Thousand
- Currency
- SEK
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 6.3-11.75
- PE
- -18.12
- EPS
- -0.34
- Beta Value
- 0.567
- ISIN
- DK0060775872
- CUSIP
- -
- CIK
- -
- Shares
- 56080700.0
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Dr. Claus Elsborg Olesen
- Employee Count
- -
- Website
- https://www.initiatorpharma.com
- Ipo Date
- 2017-03-16
- Details
- Initiator Pharma A/S, a clinical stage life science company, develops drugs targeting unmet medical needs within the central and peripheral nervous system. It develops IP2018, a monoamine reuptake inhibitor for the treatment of psychogenic erectile dysfunction; IPED2015 to treat patients suffering from organic erectile dysfunction; and IPTN2021 for targeting an orphan drug indication in severe neuropathic pain. The company's pre-clinical stage candidates include IPNP2015 for the treatment of chronic pain; and IPDP2015 for depression. Initiator Pharma A/S was incorporated in 2016 and is headquartered in Copenhagen, Denmark.
More Stocks
-
CAKE
-
SPMTFSpearmint Resources Inc.
SPMTF
-
ALCOFCofidur S.A.
ALCOF
-
PREV-BPrevas AB
PREV-B
-
PHRM
-
GAGV
-
NCEN
-
007700F&F Holdings Co., Ltd.
007700